SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
redlight111
Lv1
40 积分
2024-02-28 加入
最近求助
最近应助
互助留言
Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial
7天前
已完结
Tirzepatide for Maintenance of Weight Reduction in Adults with Obesity—Reply
9天前
已关闭
Poly-Agonist Pharmacotherapies for Metabolic Diseases: Hopes and New Challenges
13天前
已完结
Anti-obesity pharmacotherapy in adults with chronic kidney disease
14天前
已完结
Cardiovascular protection significantly depends on HbA1c improvement with GLP-1RAs but not with SGLT2 is in type 2 diabetes: a narrative review
14天前
已完结
GLP-1 receptor agonists and vascular protection
16天前
已完结
Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes
18天前
已完结
Updated Meta-Analysis Assessing the Cardiovascular Efficacy of Tirzepatide
21天前
已完结
Obesity, Cardiovascular Disease, and the Promising Role of Semaglutide: Insights from the SELECT Trial
21天前
已完结
Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A State-of-the-Art Review
22天前
已完结
没有进行任何应助
感谢
1个月前
速度真快
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论